Department of Infectious Diseases, Ningbo First Hospital, Ningbo, 315010, Zhejiang, China.
Department of Hepatology, Ningbo First Hospital, Ningbo, 315010, Zhejiang, China.
BMC Endocr Disord. 2022 Aug 31;22(1):220. doi: 10.1186/s12902-022-01134-z.
Type 2 diabetes mellitus (T2DM) is a well-known independent risk factor for non-alcoholic fatty liver disease (NAFLD). However, research exploring the association between blood glucose management and the risk of NAFLD status in subjects without diabetes was insufficient. This study aimed to explore the association of glycated hemoglobin (HbA1c) with NAFLD status and the severity of liver steatosis and fibrosis in non-diabetic people.
A cross-sectional analysis was conducted on 2998 non-diabetic American adults using data from the National Health and Nutrition Examination Survey (NHANES) 2017-2018 cycle. We used multivariable logistic regression models to evaluate the association between HbA1c and NAFLD status and the severity of liver steatosis and fibrosis. Interaction and stratified analyses were additionally performed.
The multivariate regression analyses showed that HbA1c was associated independently with NAFLD status in all the models (model1: OR = 2.834, 95%CI: 2.321, 3.461; model 2: OR = 2.900, 95%CI: 2.312, 3.637 and model 3: OR = 1.664, 95%CI: 1.284, 2.156). We further performed the interaction and stratified analyses and discovered a significant interaction between HbA1c and BMI (P < 0.05). Finally, a robust link was shown between HbA1c level and the severity of liver steatosis, which was mainly significant in the prediabetes group, while the correlation was not significant in HbA1c level and severity of liver fibrosis after controlling for all the potential confounders.
We concluded that HbA1c level was positively correlated to the risk of developing NAFLD in a large non-diabetic American population. Moreover, HbA1c level was associated with the severity of liver steatosis in subjects with prediabetes, suggesting that routine screening for HbA1c among individuals with prediabetes is necessary.
2 型糖尿病(T2DM)是众所周知的非酒精性脂肪肝疾病(NAFLD)的独立危险因素。然而,研究探索血糖管理与非糖尿病患者 NAFLD 状态风险之间的关系的研究还不够充分。本研究旨在探讨糖化血红蛋白(HbA1c)与非糖尿病人群的 NAFLD 状态以及肝脂肪变性和纤维化严重程度的关系。
使用 2017-2018 年全国健康和营养调查(NHANES)的数据,对 2998 名非糖尿病的美国成年人进行了横断面分析。我们使用多变量逻辑回归模型来评估 HbA1c 与 NAFLD 状态以及肝脂肪变性和纤维化严重程度之间的关系。另外还进行了交互作用和分层分析。
多变量回归分析表明,HbA1c 与所有模型中的 NAFLD 状态独立相关(模型 1:OR=2.834,95%CI:2.321,3.461;模型 2:OR=2.900,95%CI:2.312,3.637 和模型 3:OR=1.664,95%CI:1.284,2.156)。我们进一步进行了交互作用和分层分析,发现 HbA1c 和 BMI 之间存在显著的交互作用(P<0.05)。最后,我们发现 HbA1c 水平与肝脂肪变性的严重程度之间存在稳健的联系,这主要在糖尿病前期组中显著,而在控制了所有潜在混杂因素后,HbA1c 水平与肝纤维化的严重程度之间的相关性不显著。
我们的结论是,在一个大型的非糖尿病美国人群中,HbA1c 水平与 NAFLD 的发病风险呈正相关。此外,HbA1c 水平与糖尿病前期患者的肝脂肪变性严重程度相关,提示在糖尿病前期人群中常规筛查 HbA1c 是必要的。